PREGABALIN LAPL pregabalin 50 mg capsule blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

pregabalin, Quantity: 50 mg

Disponible desde:

Lupin Australia Pty Limited

Designación común internacional (DCI):

Pregabalin

formulario farmacéutico:

Capsule, hard

Composición:

Excipient Ingredients: pregelatinised maize starch; purified talc; titanium dioxide; purified water; Gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute

Vía de administración:

Oral

Unidades en paquete:

20, 14, 56, 60

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Pregabalin LAPL is indicated for the treatment of neuropathic pain in adults. Pregabalin LAPL is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Resumen del producto:

Visual Identification: Size '4' capsules with white cap and white body, imprinted with "PG" on the cap and with a band and with "50" on the body in black ink, containing white to off white powder; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Licence status A

Fecha de autorización:

2014-12-05